Margaret Billingsley
Assistant Professor of Biomedical Engineering
About
As part of the NanoSTAR Institute and University of Virginia School of Medicine, the Billingsley Lab explores the interface of biomaterials, nanotechnology, and clinical cancer research. Working with the Manning Institute of Biotechnology and the UVA Comprehensive Cancer Center, our team develops translatable nanoparticle platforms for precise drug delivery and immune cell engineering to improve therapies for sex-specific diseases including gynecological cancers.
Education
Ph.D., Bioengineering and Biomedical Engineering, University of Pennsylvania
B.S., Bioengineering and Biomedical Engineering, University of Delaware